Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'UROKINASE-TYPE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 419 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ogura, N; Tobe, M; Tamaki, H; Nagura, H; Abiko, Y
      IL-1 beta increases uPA and uPA receptor expression in human gingival fibroblasts

      IUBMB LIFE
    2. Gabler, C; Killian, GJ; Einspanier, R
      Differential expression of extracellular matrix components in the bovine oviduct during the oestrous cycle

      REPRODUCTION
    3. Zore, I; Krasovec, M; Cimerman, N; Kuhelj, R; Werle, B; Nielsen, HJ; Brunner, N; Kos, J
      Cathepsin B/cystatin C complex levels in sera from patients with lung and colorectal cancer

      BIOLOGICAL CHEMISTRY
    4. Gonias, SL; Hembrough, TA; Sankovic, M
      Cytokeratin 8 functions as a major plasminogen receptor in select epithelial and carcinoma cells

      FRONTIERS IN BIOSCIENCE
    5. Schermuly, RT; Gunther, A; Ermert, M; Ermert, L; Ghofrani, HA; Weissmann, N; Grimminger, F; Seeger, W; Walmrath, D
      Conebulization of surfactant and urokinase restores gas exchange in perfused lungs with alveolar fibrin formation

      AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
    6. Teraoka, H; Sawada, T; Yamashita, Y; Nakata, B; Ohira, M; Ishikawa, T; Nishino, H; Hirakawa, K
      TGF-beta 1 promotes liver metastasis of pancreatic cancer by modulating the capacity of cellular invasion

      INTERNATIONAL JOURNAL OF ONCOLOGY
    7. Pelayo, BA; Fu, YM; Meadows, GG
      Decreased tissue plasminogen activator and increased plasminogen activatorinhibitors and increased activator protein-1 and specific promoter 1 are associated with inhibition of invasion in human A375 melanoma deprived of tyrosine and phenylalanine

      INTERNATIONAL JOURNAL OF ONCOLOGY
    8. Takanami, I; Takeuchi, K; Karuke, M
      Expression of Ets-1 is correlated with urokinase-type plasminogen activator and poor prognosis in pulmonary adenocarcinoma

      TUMOR BIOLOGY
    9. Ishii, K; Usui, S; Sugimura, Y; Yamamoto, H; Yoshikawa, K; Hirano, K
      Inhibition of aminopeptidase N (AP-N) and urokinase-type plasminogen activator (uPA) by zinc suppresses the invasion activity in human urological cancer cells

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    10. Ishii, K; Usui, S; Sugimura, Y; Yamamoto, H; Yoshikawa, K; Hirano, K
      Extract from Serenoa repens suppresses the invasion activity of human urological cancer cells by inhibiting urokinase-type plasminogen activator

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    11. Konno, H; Abe, J; Kaneko, T; Baba, M; Shoji, A; Sunayama, K; Kamiya, K; Tanaka, T; Suzuki, S; Nakamura, S; Urano, T
      Urokinase receptor and vascular endothelial growth factor are synergistically associated with the liver metastasis of colorectal cancer

      JAPANESE JOURNAL OF CANCER RESEARCH
    12. Kutz, SM; Providence, KM; Higgins, PJ
      Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-Stimulated PAI-1 gene expression and directed motility in renal epithelial cells

      CELL MOTILITY AND THE CYTOSKELETON
    13. Chappuis, PO; Dieterich, B; Sciretta, V; Lohse, C; Bonnefoi, H; Remadi, S; Sappino, AP
      Functional evaluation of plasmin formation in primary breast cancer

      JOURNAL OF CLINICAL ONCOLOGY
    14. Angelici, E; Contini, C; Spezzano, M; Romani, R; Carfagna, P; Serra, P; Canipari, R
      Plasminogen activator production in a rat model of Pneumocystis carinii pneumonia

      MICROBIOLOGY AND IMMUNOLOGY
    15. Uszynski, M; Maciejewski, K; Uszynski, W; Kuczynski, J
      Placenta and myometrium - The two main sources of fibrinolytic components during pregnancy

      GYNECOLOGIC AND OBSTETRIC INVESTIGATION
    16. Harbeck, N; Kruger, A; Sinz, S; Kates, RE; Thomssen, C; Schmitt, M; Janicke, F
      Clinical relevance of the plasminogen activator inhibitor type 1 - a multifaceted proteolytic factor

      ONKOLOGIE
    17. Song, L; Ryan, PL; Porter, DG; Coomber, BL
      Effects of relaxin on matrix remodeling enzyme activity of cultured equineovarian stromal cells

      ANIMAL REPRODUCTION SCIENCE
    18. Okuyama, T; Oya, M; Ishikawa, H
      Isolated splenic metastasis of sigmoid colon cancer: a case report

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    19. Nieto-Rodriguez, A; Hernandez-Pando, R; Kershenobich, D; Rodriguez-Fragoso, L
      Expression of urokinase-type plasminogen activator in an experimental model of hepatocarcinoma

      TOXICOLOGY
    20. Ichiki, K; Mitani, N; Doki, Y; Hara, H; Misaki, T; Saiki, I
      Regulation of activator protein-1 activity in the mediastinal lymph node metastasis of lung cancer

      CLINICAL & EXPERIMENTAL METASTASIS
    21. Jiao, JW; Yu, MM; Ru, BG
      Characterization of a recombinant chimeric plasminogen activator with enhanced fibrin binding

      BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY
    22. Rijken, DC; Sakharov, DV
      Basic principles in thrombolysis: Regulatory role of plasminogen

      THROMBOSIS RESEARCH
    23. Gao, WQ; Wang, ZY; Bai, X; Xi, XD; Ruan, CG
      Detection of soluble urokinase receptor by immunoradiometric assay and itsapplication in tumor patients

      THROMBOSIS RESEARCH
    24. Vesce, F; Scapoli, C; Giovannini, G; Piffanelli, A; Geurts-Moespot, A; Sweep, FCGJ
      Plasminogen activator system in serum and amniotic fluid of euploid and aneuploid pregnancies

      OBSTETRICS AND GYNECOLOGY
    25. Ronfard, V; Barrandon, Y
      Migration of keratinocytes through tunnels of digested fibrin

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    26. Braungart, E; Magdolen, V; Degitz, K
      Retinoic acid upregulates the plasminogen activator system in human epidermal keratinocytes

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    27. Zhong, M; Webb, DJ; Jo, M; Gonias, SL
      Endogenously produced urokinase-type plasminogen activator is a major determinant of the basal level of activated ERK/MAP kinase and prevents apoptosis in MDA-MB-231 breast cancer cells

      JOURNAL OF CELL SCIENCE
    28. Kjoller, L; Hall, A
      Rac mediates cytoskeletal rearrangements and increased cell motility induced by urokinase-type plasminogen activator receptor binding to vitronectin

      JOURNAL OF CELL BIOLOGY
    29. Webb, DJ; Thomas, KS; Gonias, SL
      Plasminogen activator inhibitor 1 functions as a urokinase response modifier at the level of cell signaling and thereby promotes MCF-7 cell growth

      JOURNAL OF CELL BIOLOGY
    30. Egelund, R; Einholm, AP; Pedersen, KE; Nielsen, RW; Christensen, A; Deinum, J; Andreasen, PA
      A regulatory hydrophobic area in the flexible joint region of plasminogen activator inhibitor-1, defined with fluorescent activity-neutralizing ligands - Ligand-induced serpin polymerization

      JOURNAL OF BIOLOGICAL CHEMISTRY
    31. Wind, T; Jensen, MA; Andreasen, PA
      Epitope mapping for four monoclonal antibodies against human plasminogen activator inhibitor type-1 - Implications for antibody-mediated PAI-1-neutralization and vitronectin-binding

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    32. Egelund, R; Petersen, TE; Andreasen, PA
      A serpin-induced extensive proteolytic susceptibility of urokinase-type plasminogen activator implicates distortion of the proteinase substrate-binding pocket and oxyanion hole in the serpin inhibitory mechanism

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    33. Schenk-Braat, EAM; Morser, J; Rijken, DC
      Identification of the epidermal growth factor-like domains of thrombomodulin essential for the acceleration of thrombin-mediated inactivation of single-chain urokinase-type plasminogen activator

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    34. Laube, F; Gohring, B; Sann, H; Willhardt, I
      Cell surface antigens in renal tumour cells: detection by immunoluminescence and enzymatic analysis

      BRITISH JOURNAL OF CANCER
    35. Hoover-Plow, J; Skomorovska-Prokvolit, O; Welsh, S
      Selective behaviors altered in plasminogen-deficient mice are reconstituted with intracerebroventricular injection of plasminogen

      BRAIN RESEARCH
    36. Lindberg, P; Kinnby, B; Lecander, I; Lang, NP; Matsson, L
      Increasing expression of tissue plasminogen activator and plasminogen activator inhibitor type 2 in dog gingival tissues with progressive inflammation

      ARCHIVES OF ORAL BIOLOGY
    37. Chan, JCY; Duszczyszyn, DA; Castellino, FJ; Ploplis, VA
      Accelerated skin wound healing in plasminogen activator inhibitor-1-deficient mice

      AMERICAN JOURNAL OF PATHOLOGY
    38. Blankesteijn, WM; Creemers, E; Lutgens, E; Cleutjens, JPM; Daemen, MJAP; Smits, JFM
      Dynamics of cardiac wound healing following myocardial infarction: observations in genetically altered mice

      ACTA PHYSIOLOGICA SCANDINAVICA
    39. Rijken, DC; Sakharov, DV
      Molecular transport during fibrin clot lysis

      FIBRINOLYSIS & PROTEOLYSIS
    40. Dunbar, SD; Ornstein, DL; Zacharski, LR
      Cancer treatment with inhibitors of urokinase-type plasminogen activator and plasmin

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    41. Connell, RD
      Cancer chemotherapeutics - angiogenesis agents: October 1999-March 2000

      EXPERT OPINION ON THERAPEUTIC PATENTS
    42. Okusa, Y; Ichikura, T; Mochizuki, H; Shinomiya, N
      Urokinase type plasminogen activator and its receptor regulates the invasive potential of gastric cancer cell lines

      INTERNATIONAL JOURNAL OF ONCOLOGY
    43. Stacey, MC; Mata, SD
      Lower levels or PAI-2 may contribute to impaired healing in venous ulcers - a preliminary study

      CARDIOVASCULAR SURGERY
    44. Gurewich, V
      Fibrinolysis: an unfinished agenda

      BLOOD COAGULATION & FIBRINOLYSIS
    45. Schaefer, BM; Wallich, R; Schmolke, K; Fink, W; Bechtel, M; Reinartz, J; Kramer, MD
      Immunohistochemical and molecular characterization of cultured keratinocytes after dispase-mediated detachment from the growth substratum

      EXPERIMENTAL DERMATOLOGY
    46. Dunn, SE; Torres, JC; Nihei, N; Barrett, JC
      The insulin-like growth factor-1 elevates urokinase-type plasminogen activator-1 in human breast cancer cells: A new avenue for breast cancer therapy

      MOLECULAR CARCINOGENESIS
    47. Itoh, T; Hayashi, Y; Kanamaru, T; Morita, Y; Suzuki, S; Wang, WP; Zhou, L; Rui, JA; Yamamoto, M; Kuroda, Y; Itoh, H
      Clinical significance of urokinase-type plasminogen activator activity in hepatocellular carcinoma

      JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
    48. Raigoso, P; Junco, A; Andicoechea, A; Gonzalez, A; Garcia-Muniz, JL; Allende, MT; Garcia-Moran, M; Vizoso, F
      Tissue-type plasminogen activator (tPA) content in colorectal cancer and in surrounding mucosa: relationship with clinicopathologic parameters and prognostic significance

      INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
    49. Gupta, B; Singh, N; Saxena, KK; Srivastava, VK
      Topical amiloride solution accelerates healing of mechanical skin ulcers in albino rats

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    50. Kobayashi, H
      Invasive capacity of heterotopic endometrium

      GYNECOLOGIC AND OBSTETRIC INVESTIGATION
    51. Schousboe, SL; Egelund, R; Kirkegaard, T; Preissner, KT; Rodenburg, KW; Andreasen, PA
      Vitronectin and substitution at a beta-strand 5A lysine residue potentiateactivity-neutralization of PA inhibitor-1 by monoclonal antibodies againstalpha-helix F

      THROMBOSIS AND HAEMOSTASIS
    52. Nonaka, T; Kikuchi, H; Ikeda, T; Okamoto, Y; Hamanishi, C; Tanaka, S
      Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in humansynovial fibroblasts of osteoarthritis and rheumatoid arthritis

      JOURNAL OF RHEUMATOLOGY
    53. Beschorner, R; Schluesener, HJ; Nguyen, TD; Magdolen, V; Luther, T; Pedal, I; Mattern, R; Meyermann, R; Schwab, JM
      Lesion-associated accumulation of uPAR/CD87-expressing infiltrating granulocytes, activated microglial cells/macrophages and upregulation by endothelial cells following TBI and FCI in humans

      NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
    54. Tang, HB; Fu, WY; Ip, NY
      Altered expression of tissue-type plasminogen activator and type 1 inhibitor in astrocytes of mouse cortex following scratch injury in culture

      NEUROSCIENCE LETTERS
    55. Rha, SY; Yang, WI; Gong, SJ; Kim, JJ; Yoo, NC; Roh, JK; Min, JS; Lee, KS; Kim, BS; Chung, HC
      Correlation of tissue and blood plasminogen activation system in breast cancer

      CANCER LETTERS
    56. Pokorny, RM; Hunt, LE; Galandiuk, S
      What's new with tumor markers for colorectal cancer?

      DIGESTIVE SURGERY
    57. Laube, F
      Co-localization of CD44 and urokinase-type plasminogen activator on the surface of human melanoma cells

      ANTICANCER RESEARCH
    58. Strojan, P; Budihna, M; Smid, L; Vrhovec, I; Skrk, J
      Urokinase-type plasminogen activator, plasminogen activator inhibitor type1 and cathepsin D: Analysis of their prognostic significance in squamous cell carcinoma of the head and neck

      ANTICANCER RESEARCH
    59. Morii, T; Yabe, H; Morioka, H; Yamada, R; Nakagawa, T; Toyama, Y
      Prognostic relevance of urokinase type plasminogen activator, its receptorand inhibitors in chondrosarcoma

      ANTICANCER RESEARCH
    60. Kobayashi, H; Suzuki, M; Sun, GW; Hirashima, Y; Terao, T
      Suppression of urokinase-type plasminogen activator expression from human ovarian cancer cells by urinary trypsin inhibitor

      BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY
    61. Park, IK; Lyu, MA; Yeo, SJ; Han, TH; Kook, YH
      Sp1 mediates constitutive and transforming growth factor beta-inducible expression of urokinase type plasminogen activator receptor gene in human monocyte-like U937 cells

      BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION
    62. Nishino, T; Yamauchi, T; Horie, M; Nagumo, T; Suzuki, H
      Effects of a fucoidan on the activation of plasminogen by u-PA and t-PA

      THROMBOSIS RESEARCH
    63. Muehlenweg, B; Guthaus, E; de Prada, NA; Schmitt, M; Schmiedeberg, N; Kotzsch, M; Creutzburg, S; Kramer, MD; Kessler, H; Wilhelm, OG; Magdolen, V
      Epitope mapping of monoclonal antibodies directed to PAI-1 using PAI-1/PAI-2 chimera and PAI-1-derived synthetic peptides

      THROMBOSIS RESEARCH
    64. Ohta, S; Niiya, K; Sakuragawa, N; Fuse, H
      Induction of urokinase-type plasminogen activator by lipopolysaccharide inPC-3 human prostatic cancer cells

      THROMBOSIS RESEARCH
    65. Falk, P; Ma, C; Chegini, N; Holmdahl, L
      Differential regulation of mesothelial cell fibrinolysis by transforming growth factor beta 1

      SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
    66. Sperl, S; Jacob, U; de Prada, NA; Sturzebecher, J; Wilhelm, OG; Bode, W; Magdolen, V; Huber, R; Moroder, L
      (4-Aminomethyl)phenylguanidine derivatives as nonpeptidic highly selectiveinhibitors of human urokinase

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    67. Dubuisson, L; Monvoisin, A; Nielsen, BS; Le Bail, B; Bioulac-Sage, P; Rosenbaum, J
      Expression and cellular localization of the urokinase-type plasminogen activator and its receptor in human hepatocellular carcinoma

      JOURNAL OF PATHOLOGY
    68. Jaeger, C; Schaefer, BM; Wallich, R; Kramer, MD
      The membrane-associated protein pKe#192/MAP17 in human keratinocytes

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    69. Graeven, U; Rodeck, U; Karpinski, S; Jost, M; Andre, N; Schmiegel, W
      Expression patterns of placenta growth factor in human melanocytic cell lines

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    70. Di Matola, T; Mueller, F; Fenzi, G; Rossi, G; Bifulco, M; Marzano, LA; Vitale, M
      Serum withdrawal-induced apoptosis in thyroid cells is caused by loss of fibronectin-integrin interaction

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    71. Podor, TJ; Peterson, CB; Lawrence, DA; Stefansson, S; Shaughnessy, SG; Foulon, DM; Butcher, M; Weitz, JI
      Type 1 plasminogen activator inhibitor binds to fibrin via vitronectin

      JOURNAL OF BIOLOGICAL CHEMISTRY
    72. Salame, MY; Samani, NJ; Masood, I; deBono, DP
      Expression of the plasminogen activator system in the human vascular wall

      ATHEROSCLEROSIS
    73. Festuccia, C; Angelucci, A; Gravina, GL; Villanova, I; Teti, A; Abini, A; Bologna, M
      Osteoblast-derived TGF-beta 1 modulates matrix degrading protease expression and activity in prostate cancer cells

      INTERNATIONAL JOURNAL OF CANCER
    74. Sidenius, N; Sier, CFM; Blasi, F
      Shedding and cleavage of the urokinase receptor (uPAR): identification andcharacterisation of uPAR fragments in vitro and in vivo

      FEBS LETTERS
    75. Wang, AY; Dang, JJ; Wang, H; Allgayer, N; Murrell, GAC; Boyd, D
      Identification of a novel nuclear factor-kappaB sequence involved in expression of urokinase-type plasminogen activator receptor

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    76. Kitange, G; Tsunoda, K; Anda, T; Nakamura, S; Yasunaga, A; Naito, S; Shibata, S
      Immunohistochemical expression of Ets-1 transcription factor and the urokinase-type plasminogen activator is correlated with the malignant and invasive potential in meningiomas

      CANCER
    77. Ferrier, CM; Suciu, S; van Geloof, WL; Straatman, H; Eggermont, AMM; Koops, HS; Kroon, BBR; Lejeune, FJ; Kleeberg, UR; van Muijen, GNP; Ruiter, DJ
      High tPA-expression in primary melanoma of the limb correlates with good prognosis

      BRITISH JOURNAL OF CANCER
    78. Canipari, R; Galdieri, M
      Retinoid modulation of plasminogen activator production in rat sertoli cells

      BIOLOGY OF REPRODUCTION
    79. Hoffmann, G; Pollow, K; Weikel, W; Strittmatter, HJ; Bach, J; Schaffrath, M; Knapstein, P; Melchert, F; Pollow, B
      Urokinase and plasminogen activator-inhibitor (PAI-1) status in primary ovarian carcinomas and ovarian metastases compared to benign ovarian tumors as a function of histopathological parameters

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    80. Gunnarsson, M; Lecander, I; Abrahamsson, PA
      Factors of the plasminogen activator system in human testis, as demonstrated by in-situ hybridization and immunohistochemistry

      MOLECULAR HUMAN REPRODUCTION
    81. Hoover-Plow, J; Wang, NZ; Ploplis, V
      Growth and behavioral development in plasminogen gene-targeted mice

      GROWTH DEVELOPMENT AND AGING
    82. Kariko, K; Kuo, A; Barnathan, ES
      Overexpression of urokinase receptor in mammalian cells following administration of the in vitro transcribed encoding mRNA

      GENE THERAPY
    83. Wu, WJ; Yamaura, T; Murakami, K; Ogasawara, M; Hayashi, K; Murata, J; Saiki, I
      Involvement of TNF-alpha in enhancement of invasion and metastasis of colon 26-L5 carcinoma cells in mice by social isolation stress

      ONCOLOGY RESEARCH
    84. Adermann, K; Wattler, F; Wattler, S; Heine, G; Meyer, M; Forssmann, WG; Nehls, M
      Structural and phylogenetic characterization of human SLURP-1, the first secreted mammalian member of the Ly-6/uPAR protein superfamily

      PROTEIN SCIENCE
    85. Alexander, CL; Edward, M; MacKie, RM
      Effect of retinoic acid on plasminogen activator expression in human melanoma cells

      MELANOMA RESEARCH
    86. Wang, WX; Abbruzzese, JL; Evans, DB; Chiao, PJ
      Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA

      ONCOGENE
    87. Herouy, Y; Stetter, C; Schopf, E; Norgauer, J; Vanscheidt, W
      Gene expression of fibrinolytic factors of the urokinase-plasmin-system inlipodermatosclerosis

      PHLEBOLOGIE
    88. Sunagawa, M; Kinjoh, K; Nakamura, M; Kosugi, T
      Urokinase-type plasminogen activator and plasminogen activator inhibitor antigen in tissue extracts of paranasal sinus mucous membranes affected by chronic sinusitis and antrochoanal polyps

      EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
    89. Maksimenko, AV; Tischenko, EG
      New thrombolytic strategy: Bolus administration of tPA and urokinase-fibrinogen conjugate

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    90. Meijer-van Gelder, ME; Look, MP; Bolt-de Vries, J; Peters, HA; Klijn, JGM; Foekens, JA
      Breast-conserving therapy: Proteases as risk factors in relation to survival after local relapse

      JOURNAL OF CLINICAL ONCOLOGY
    91. Sood, AK; Gupta, B; Chugh, P
      Topical amiloride accelerates healing and delays neovascularization in mechanically produced corneal ulcers in rabbits

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    92. Yokoyama-Kobayashi, M; Yamaguchi, T; Sekine, S; Kato, S
      Selection of cDNAs encoding putative type II membrane proteins on the cellsurface from a human full-length cDNA bank

      GENE
    93. Kammori, M; Kaminishi, M; Kobayashi, K; Oohara, T; Endo, H; Takubo, K; Hashimoto, H
      Immunohistochemical analysis of PAI-2 (plasminogen activator inhibitor type 2) and p53 protein in early gastric cancer patients with recurrence: a preliminary report

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    94. Nowak-Gottl, U; Munchow, N; Klippel, U; Paulussen, M; Bielack, S; Ullrich, K; Ehrenforth, S
      The course of fibrinolytic proteins in children with malignant bone tumours

      EUROPEAN JOURNAL OF PEDIATRICS
    95. Kitayoshi, H; Inoue, N; Kuwae, K; Chen, ZL; Sato, H; Ohta, T; Hosokawa, K; Itami, S; Yoshikawa, K; Yoshida, S; Shiosaka, S
      Effect of 12-O-tetradecanoyl-phorbol ester and incisional wounding on neuropsin mRNA and its protein expression in murine skin

      ARCHIVES OF DERMATOLOGICAL RESEARCH
    96. Sieuwerts, AM; Klijn, JGM; Foekens, JA
      Insulin-like growth factor 1 (ICF-1) and urokinase-type plasminogen activator (uPA) are inversely related in human breast fibroblasts

      MOLECULAR AND CELLULAR ENDOCRINOLOGY
    97. Fishman, DA; Kearns, A; Larsh, S; Enghild, JJ; Stack, MS
      Autocrine regulation of growth stimulation in human epithelial ovarian carcinoma by serine-proteinase-catalysed release of the urinary-type-plasminogen-activator N-terminal fragment

      BIOCHEMICAL JOURNAL
    98. Moriyama, T; Kataoka, H; Hamasuna, R; Yoshida, E; Sameshima, T; Iseda, T; Yokogami, K; Nakano, S; Koono, M; Wakisaka, S
      Simultaneous up-regulation of urokinase-type plasminogen activator (uPA) and uPA receptor by hepatocyte growth factor/scatter factor in human glioma cells

      CLINICAL & EXPERIMENTAL METASTASIS
    99. Lund, LR; Romer, J; Bugge, TH; Nielsen, BS; Frandsen, TL; Degen, JL; Stephens, RW; Dano, K
      Functional overlap between two classes of matrix-degrading proteases in wound healing

      EMBO JOURNAL
    100. Ueda, M; Fujii, H; Yoshizawa, K; Terai, Y; Kumagai, K; Ueki, K; Ueki, M
      Effects of EGF and TGF-alpha on invasion and proteinase expression of uterine cervical adenocarcinoma OMC-4 cells

      INVASION & METASTASIS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/08/20 alle ore 11:46:28